The pharmacokinetics and the pharmacodynamics of cannabinoids

There is increasing interest in the use of cannabinoids for disease and symptom management, but limited information available regarding their pharmacokinetics and pharmacodynamics to guide prescribers. Cannabis medicines contain a wide variety of chemical compounds, including the cannabinoids delta‐9‐tetrahydrocannabinol (THC), which is psychoactive, and the nonpsychoactive cannabidiol (CBD). Cannabis use is associated with both pathological and behavioural toxicity and, accordingly, is contraindicated in the context of significant psychiatric, cardiovascular, renal or hepatic illness.

Effect of Marihuana on Intraocular and Blood Pressure in Glaucoma

Author: John C.Merritt MD, William J.Crawford PhD, Paul C.Alexander MD, Alfred L.Anduze MD, Solomon S.Gelbart MD Published in Science Direct March 1980 Abstract Marihuana inhalation was accompanied by increased heart rate…